PF-04880594 is primarily used in research and development within the pharmaceutical industry. It is studied for its potential as a therapeutic agent, particularly in the treatment of cancer. The compound is investigated for its ability to inhibit specific enzymes or pathways that are crucial for the growth and survival of cancer cells. Researchers explore its efficacy in preclinical models to determine its potential for further clinical trials. Additionally, it may be used in biochemical assays to better understand cellular mechanisms and drug interactions. Its application is largely confined to laboratory settings, where it contributes to advancing knowledge in oncology and drug discovery.